IGC Pharma, Inc. (IGC): Shareholders' Equity
Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$6.33M
As of 2025-03-31
-35.8%
3-year compound annual growth
-7.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $6.33M | -13.5% | 2025-06-27, Balance as of period end |
| 2024-03-31 | $7.32M | -50.9% | 2025-06-27, Balance as of period end |
| 2023-03-31 | $14.91M | -37.6% | 2024-06-24, Balance as of period end |
| 2022-03-31 | $23.89M | -27.2% | 2023-07-07, Balance as of period end |
| 2021-03-31 | $32.80M | n/a | 2022-06-23, Balance as of period end |
| No annual figure between 2018-03-31 and 2021-03-31. | |||
| 2018-03-31 | $8.06M | +9.6% | 2018-06-21, Balance as of period end |
| 2017-03-31 | $7.36M | -45.4% | 2018-06-21, Balance as of period end |
| 2016-03-31 | $13.48M | -5.3% | 2017-07-14, Balance as of period end |
| 2015-03-31 | $14.23M | +4.5% | 2016-07-14, Balance as of period end |
| 2014-03-31 | $13.63M | -5.6% | 2015-07-14, Balance as of period end |
| 2013-03-31 | $14.44M | -2.7% | 2014-07-15, Balance as of period end |
| 2012-03-31 | $14.84M | +122.6% | 2014-07-15, Balance as of period end |
| 2011-03-31 | $6.67M | n/a | 2012-07-16, Balance as of period end |